Dapidran, Edrian .

HRN: 09-34-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
CEFUROXIME 750MG (VIAL)
09/29/2025
10/06/2025
IV
750mg
Q 8 Hours
Acute Bacterial Infection T/C AGE
Pending Pharmacy Acceptance 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: